$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024069089 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$1.753M	$1.253M
YoY Change	-55.79%	-75.41%
Cost Of Revenue	$1.879M	$1.094M
YoY Change	-58.26%	-78.39%
Gross Profit	-$125.6K	$159.2K
YoY Change	-76.57%	373.29%
Gross Profit Margin	-7.16%	12.7%
Selling, General & Admin	$353.7K	$1.223M
YoY Change	-78.16%	-16.22%
% of Gross Profit		768.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$104.8K	$42.30K
YoY Change	12.75%	-54.26%
% of Gross Profit		26.57%
Operating Expenses	$2.116M	$2.953M
YoY Change	-13.27%	-47.68%
Operating Profit	-$2.241M	-$2.794M
YoY Change	-24.67%	-50.21%
Interest Expense		-$1.889M
YoY Change		-460.58%
% of Operating Profit
Other Income/Expense, Net	-$1.475M	-$1.754M
YoY Change	133.02%	-3269.77%
Pretax Income	-$3.716M	-$4.548M
YoY Change	2.99%	-18.14%
Income Tax
% Of Pretax Income
Net Earnings	-$3.716M	-$4.548M
YoY Change	2.99%	-18.14%
Net Earnings / Revenue	-211.96%	-362.83%
Basic Earnings Per Share		-$2.73
Diluted Earnings Per Share		-$2.73
COMMON SHARES
Basic Shares Outstanding	2.028M shares	1.218M shares
Diluted Shares Outstanding	2.089M shares	1.412M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.017M
YoY Change		-36.5%
Cash & Equivalents	$257.0K	$1.017M
Short-Term Investments
Other Short-Term Assets	$1.919M	$4.080M
YoY Change	-52.03%	82.75%
Inventory	$742.1K	$223.4K
Prepaid Expenses
Receivables	$168.2K	$364.4K
Other Receivables		$0.00
Total Short-Term Assets	$2.001M	$7.398M
YoY Change	-71.83%	-20.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.206M	$5.506M
YoY Change	-39.05%	-21.24%
Goodwill		$1.811M
YoY Change		38.3%
Intangibles	$15.08K	$557.3K
YoY Change	-99.23%	-72.09%
Long-Term Investments		$3.643M
YoY Change		-15.78%
Other Assets
YoY Change
Total Long-Term Assets	$7.798M	$13.53M
YoY Change	-57.23%	-27.01%
TOTAL ASSETS
Total Short-Term Assets	$2.001M	$7.398M
Total Long-Term Assets	$7.798M	$13.53M
Total Assets	$9.799M	$20.93M
YoY Change	-61.32%	-24.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$10.01M
YoY Change		42.4%
Accrued Expenses
YoY Change
Deferred Revenue	$755.1K	$1.737M
YoY Change	-42.41%	929.31%
Short-Term Debt		$0.00
YoY Change		-100.0%
Long-Term Debt Due	$1.846M	$10.10M
YoY Change	710.37%	1213.41%
Total Short-Term Liabilities	$13.24M	$22.31M
YoY Change	-15.59%	47.67%
LONG-TERM LIABILITIES
Long-Term Debt	$4.720M	$2.462M
YoY Change	62.93%	-18.85%
Other Long-Term Liabilities		$945.0K
YoY Change		138.03%
Total Long-Term Liabilities	$4.720M	$3.407M
YoY Change	45.95%	-0.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.24M	$22.31M
Total Long-Term Liabilities	$4.720M	$3.407M
Total Liabilities	$17.96M	$25.72M
YoY Change	-5.07%	38.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$87.44M	-$84.46M
YoY Change	40.29%	67.24%
Common Stock	$22.58K	$17.48K
YoY Change	-86.3%	-89.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$92.40K	$92.40K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity		-$9.134M
YoY Change
Total Liabilities & Shareholders Equity	$9.799M	$20.93M
YoY Change	-61.32%	-24.89%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$3.716M	-$4.548M
YoY Change	2.99%	-18.14%
Depreciation, Depletion And Amortization	$104.8K	$42.30K
YoY Change	12.75%	-54.26%
Cash From Operating Activities		-$3.694M
YoY Change		122.49%
INVESTING ACTIVITIES
Capital Expenditures		-$65.08K
YoY Change		-312.26%
Acquisitions
YoY Change
Other Investing Activities		-$20.00
YoY Change
Cash From Investing Activities		$65.06K
YoY Change		-312.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		3.906M
YoY Change		112.3%
NET CHANGE
Cash From Operating Activities		-3.694M
Cash From Investing Activities		65.06K
Cash From Financing Activities		3.906M
Net Change In Cash		277.0K
YoY Change		86.15%
FREE CASH FLOW
Cash From Operating Activities		-$3.694M
Capital Expenditures		-$65.08K
Free Cash Flow		-$3.629M
YoY Change		114.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2024Q2	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation ShareBasedCompensation	527336	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3210631	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	131599	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	201590	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	186703	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	14887	shares
CY2018Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	761401.66	usd
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2861401.66	usd
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38037
	dei	Entity Registrant Name EntityRegistrantName	SAFE & GREEN HOLDINGS CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
	dei	Entity Address Address Line1 EntityAddressAddressLine1	990 Biscayne Blvd.,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#501, Office 12
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33132
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	240-4235
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	SGBX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2027772	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1016784	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17448	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	364355	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	182753	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	113001	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	10745	usd
CY2024Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4400361	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4400361	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	223402	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	156512	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1279667	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	572779	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	7397570	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5340598	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5505596	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5582401	usd
CY2024Q2	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	789318	usd
CY2023Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	604327	usd
CY2024Q2	us-gaap	Goodwill Goodwill	1810787	usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1225370	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1987137	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	557261	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23616	usd
CY2024Q2	us-gaap	Deferred Costs DeferredCosts		usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	30589	usd
CY2024Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3642607	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3642607	usd
CY2024Q2	us-gaap	Assets Assets	20928509	usd
CY2023Q4	us-gaap	Assets Assets	17211275	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10005910	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9854263	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1737394	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1366998	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	463114	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	856088	usd
CY2024Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	10103921	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	8472080	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	22310339	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20549429	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	2462445	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2447415	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	945000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent		usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	549290	usd
CY2024Q2	us-gaap	Liabilities Liabilities	25717784	usd
CY2023Q4	us-gaap	Liabilities Liabilities	23546134	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1747992	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1747992	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	881387	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	814969	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	17480	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8814	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	75400798	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68555050	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3371	shares
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3371	shares
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	92396	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	92396	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84459662	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-75930805	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	4344505	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1124478	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4789275	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6334859	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20928509	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17211275	usd
CY2024Q2	us-gaap	Revenues Revenues	1253416	usd
CY2023Q2	us-gaap	Revenues Revenues	5097055	usd
	us-gaap	Revenues Revenues	2271347	usd
	us-gaap	Revenues Revenues	10600990	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	1094249	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	5063425	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1739232	usd
	us-gaap	Cost Of Revenue CostOfRevenue	10636832	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	159167	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	33630	usd
	us-gaap	Gross Profit GrossProfit	532115	usd
	us-gaap	Gross Profit GrossProfit	-35842	usd
CY2024Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1729729	usd
CY2023Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	4184429	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	4997798	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	5498819	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	976416	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1357159	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1921029	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3146115	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	246829	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	102900	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	439554	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	190151	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2952974	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	5644488	usd
	us-gaap	Operating Expenses OperatingExpenses	7358381	usd
	us-gaap	Operating Expenses OperatingExpenses	8835085	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2793807	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5610858	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6826266	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8870927	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1889328	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	523971	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3172084	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	811343	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	9454	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9570	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	18816	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	135365	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	569851	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	183982	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	588490	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1753963	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	55334	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2978532	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-204037	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4547770	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5555524	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9804798	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9074964	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-4547770	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-5555524	usd
	us-gaap	Profit Loss ProfitLoss	-9804798	usd
	us-gaap	Profit Loss ProfitLoss	-9074964	usd
CY2024Q2	sgbx	Common Stock Deemed Dividends And Other Adjustments CommonStockDeemedDividendsAndOtherAdjustments		usd
CY2023Q2	sgbx	Common Stock Deemed Dividends And Other Adjustments CommonStockDeemedDividendsAndOtherAdjustments		usd
	sgbx	Common Stock Deemed Dividends And Other Adjustments CommonStockDeemedDividendsAndOtherAdjustments	670881	usd
	sgbx	Common Stock Deemed Dividends And Other Adjustments CommonStockDeemedDividendsAndOtherAdjustments		usd
CY2024Q2	sgbx	Net Income Loss Including Portion Attributable To Noncontrolling Interest And After Adjustment Of Common Stock Deemed Dividends NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndAfterAdjustmentOfCommonStockDeemedDividends	-4547770	usd
CY2023Q2	sgbx	Net Income Loss Including Portion Attributable To Noncontrolling Interest And After Adjustment Of Common Stock Deemed Dividends NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndAfterAdjustmentOfCommonStockDeemedDividends	-5555524	usd
	sgbx	Net Income Loss Including Portion Attributable To Noncontrolling Interest And After Adjustment Of Common Stock Deemed Dividends NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndAfterAdjustmentOfCommonStockDeemedDividends	-10475679	usd
	sgbx	Net Income Loss Including Portion Attributable To Noncontrolling Interest And After Adjustment Of Common Stock Deemed Dividends NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndAfterAdjustmentOfCommonStockDeemedDividends	-9074964	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-689077	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1946822	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3858693	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5555524	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8528857	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9074964	usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.73
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.73
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.46
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.75
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1412159	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1412159	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	744454	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	744454	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1179150	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1179150	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	711715	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	711715	shares
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6637478	usd
CY2024Q2	sgbx	Stock Issued During Period Value Fractional Share Adjustment StockIssuedDuringPeriodValueFractionalShareAdjustment		usd
CY2024Q2	sgbx	Stock Issued During Period Value Conversion Of Debt And Interest StockIssuedDuringPeriodValueConversionOfDebtAndInterest	502086	usd
CY2024Q2	sgbx	Stock Issued During Period Value Under Economic Partnership Agreement StockIssuedDuringPeriodValueUnderEconomicPartnershipAgreement	28867	usd
CY2024Q2	sgbx	Stock Issued During Period Value For Accounts Payable Settlement StockIssuedDuringPeriodValueForAccountsPayableSettlement	489268	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3590386	usd
CY2024Q2	sgbx	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	15	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	348308	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-4547770	usd
CY2024Q2	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	1437043	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4789275	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6334859	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	527336	usd
	sgbx	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	15	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	251361	usd
	us-gaap	Dividends Common Stock DividendsCommonStock		usd
	sgbx	Stock Issued During Period Value Warrant Inducement StockIssuedDuringPeriodValueWarrantInducement	494213	usd
	sgbx	Stock Issued During Period Value Conversion Of Debt And Interest StockIssuedDuringPeriodValueConversionOfDebtAndInterest	802087	usd
	sgbx	Stock Issued During Period Value Under Economic Partnership Agreement StockIssuedDuringPeriodValueUnderEconomicPartnershipAgreement	28867	usd
	sgbx	Stock Issued During Period Value For Accounts Payable Settlement StockIssuedDuringPeriodValueForAccountsPayableSettlement	489268	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	5166849	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3590386	usd
	us-gaap	Profit Loss ProfitLoss	-9804798	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4789275	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12321638	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2554262	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	42716	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	47500	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-5555524	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9325160	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3210631	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	437325	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	47500	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	354239	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46417	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	42716	usd
	us-gaap	Profit Loss ProfitLoss	-9074964	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9325160	usd
	us-gaap	Profit Loss ProfitLoss	-9804798	usd
	us-gaap	Profit Loss ProfitLoss	-9074964	usd
	us-gaap	Depreciation Depreciation	85034	usd
	us-gaap	Depreciation Depreciation	184964	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6834	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	93410	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	30589	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	20393	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1612377	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	411811	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	761767	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	428934	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	484825	usd
	sgbx	Issuance Of Subsidiary Stock IssuanceOfSubsidiaryStock	2846013	usd
	sgbx	Issuance Of Subsidiary Stock IssuanceOfSubsidiaryStock		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	18699	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	527336	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3210631	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	181602	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-634195	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	102256	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	835925	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	66890	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	357575	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-293112	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	239441	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	211651	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	92005	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	157720	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3016961	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	370396	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-268479	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-942264	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-653213	usd
	sgbx	Increase Decrease In Assumed Liability Of Business Transferred IncreaseDecreaseInAssumedLiabilityOfBusinessTransferred		usd
	sgbx	Increase Decrease In Assumed Liability Of Business Transferred IncreaseDecreaseInAssumedLiabilityOfBusinessTransferred	15000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4618283	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3039177	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8229	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	526324	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	1082	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	184991	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	117682	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	25000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-192138	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-669006	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1588001	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2500000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3284277	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	6609512	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt		usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	706359	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	42716	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	494213	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	15	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3619253	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	46417	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5809757	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4726738	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	999336	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1018555	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17448	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	582776	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1016784	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1601331	usd
	sgbx	Cashless Warrant Exercise CashlessWarrantExercise	114	usd
	sgbx	Cashless Warrant Exercise CashlessWarrantExercise		usd
	sgbx	Fractional Common Share Adjustment FractionalCommonShareAdjustment	1	usd
	sgbx	Fractional Common Share Adjustment FractionalCommonShareAdjustment		usd
	sgbx	Common Stock Deemed Dividend CommonStockDeemedDividend	670881	usd
	sgbx	Common Stock Deemed Dividend CommonStockDeemedDividend		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1872742	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	sgbx	Prepaid Interest For Short Term Notes Payable PrepaidInterestForShortTermNotesPayable	1000000	usd
	sgbx	Prepaid Interest For Short Term Notes Payable PrepaidInterestForShortTermNotesPayable		usd
	sgbx	Common Stock Issued For Asset Acquisition CommonStockIssuedForAssetAcquisition	228360	usd
	sgbx	Common Stock Issued For Asset Acquisition CommonStockIssuedForAssetAcquisition		usd
	sgbx	Common Stock Issued For Accounts Payable Settlement CommonStockIssuedForAccountsPayableSettlement	489268	usd
	sgbx	Common Stock Issued For Accounts Payable Settlement CommonStockIssuedForAccountsPayableSettlement		usd
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	100468	usd
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1		usd
	sgbx	Noncash Or Part Noncash Acquisition Goodwill Acquired NoncashOrPartNoncashAcquisitionGoodwillAcquired	1810787	usd
	sgbx	Noncash Or Part Noncash Acquisition Goodwill Acquired NoncashOrPartNoncashAcquisitionGoodwillAcquired		usd
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	532337	usd
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1		usd
	sgbx	Noncash Or Part Noncash Acquisition Contingent Consideration Liabilities Assumed NoncashOrPartNoncashAcquisitionContingentConsiderationLiabilitiesAssumed	945000	usd
	sgbx	Noncash Or Part Noncash Acquisition Contingent Consideration Liabilities Assumed NoncashOrPartNoncashAcquisitionContingentConsiderationLiabilitiesAssumed		usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segments
CY2024Q2	sgbx	Number Of Core Product Offerings NumberOfCoreProductOfferings	3	item
CY2024Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company effected a 1-for-20 reverse stock split of its then-outstanding common stock (“May Stock Split”). All share and per share amounts set forth in the consolidated financial statements of the Company have been retroactively restated to reflect the 1-for-20 reverse stock split as if it had occurred as of the earliest period presented and unless otherwise stated, all other share and per share amounts for all periods presented in this Quarterly Report on Form 10-Q for the period ended June 30, 2024 have been adjusted to reflect the reverse stock split effected in May 2024
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1016784	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	4079790	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4079790	usd
	sgbx	Working Capital WorkingCapital	-14912769	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="font-size: 10pt;"> <div style="border-left: none; border-right: none; text-align: justify; line-height: 1.2;"> <div> <div style="border-left: none; border-right: none;"> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="font-size: 10pt; line-height: inherit;"><span style="color: black;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period, together with amounts disclosed in the related notes to the financial statements. <span style="font-family: 'times new roman', times; line-height: inherit;">The Company's estimates used in these financial statements include, but are not limited to, revenue recognition, stock-based compensation, accounts receivable reserves, inventory valuations, goodwill, the valuation allowance related to the Company’s deferred tax assets, the carrying amount of intangible assets, right of use assets and the recoverability and useful lives of long-lived assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</span></span></span></span></span></p> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
	sgbx	No Of Operating Cycles NoOfOperatingCycles	one year
	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	91978	usd
	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	2179369	usd
	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	0	usd
	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	10600990	usd
CY2024Q2	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	42162	usd
CY2024Q2	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	1211254	usd
CY2023Q2	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	0	usd
CY2023Q2	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	5097055	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1253416	usd
CY2024Q2	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5097055	usd
CY2023Q2	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2271347	usd
	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10600990	usd
	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1016784	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17448	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	68344	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1880547	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6834	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	47291	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	56558	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2852929	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'Times New Roman'; font-style: italic; font-weight: bold; line-height: inherit;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-style: italic; line-height: inherit;">–</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any </span><span style="font-family: 'Times New Roman'; line-height: inherit;">significant </span><span style="font-family: 'Times New Roman'; line-height: inherit;">credit risk on the account. <br/></span><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At <span>June 30, 2024</span> and <span>December 31, 2023</span>, 100% of the Company’s gross accounts receivable were due from <span style="border-left: none; border-right: none; line-height: inherit;">four</span> and three customers, <span style="color: #000000; font-family: 'Times New Roman', 'serif'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">respectively.</span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Revenue relating to three and two customers represented approximately 73% and 96%, <span style="color: #000000; font-family: 'Times New Roman', 'serif'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">respectively, </span>of the Company's total revenue for the <span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"><span>three months ended June 30, 2024</span></span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"> and </span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span>2023</span></span></span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">, respectively. <span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;">Revenue relating to<span> four</span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;"><span> </span>and<span> one </span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;">customers represented approximately<span> <span style="border-left: none; border-right: none;">88%</span></span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;"> and<span> 96%</span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;"> of the Company's total revenue for the<span> </span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; float: none; line-height: inherit; display: inline !important;"><span>six months ended June 30, 2024</span> and <span>2023</span>, respectively.</span></span></span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0in 0in 0in 0.5in; text-align: justify; line-height: 12pt; font-size: 10pt; font-family: 'Times New Roman', serif;"><span style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">There were no vendors representing 10% or more of the Company’s total cost of revenue for the <span>three and six</span> months ended <span>June 30, 2024</span> and <span>2023</span>. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers. </span></p>
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	495743	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	819887	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	131388	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	637134	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	364355	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	182753	usd
CY2024Q2	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	1300383	usd
CY2023Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	20213733	usd
CY2024Q2	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2023Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2024Q2	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-376181	usd
CY2023Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-968040	usd
CY2024Q2	sgbx	Contract Assets Gross ContractAssetsGross	924202	usd
CY2023Q4	sgbx	Contract Assets Gross ContractAssetsGross	19245693	usd
CY2024Q2	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	2548595	usd
CY2023Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	20601946	usd
CY2024Q2	sgbx	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-1624393	usd
CY2023Q4	sgbx	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-1356253	usd
CY2024Q2	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	113001	usd
CY2023Q4	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	10745	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1737394	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1366998	usd
CY2024Q2	sgbx	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-1624393	usd
CY2023Q4	sgbx	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-1356253	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6101652	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6093423	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	596056	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	511022	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5505596	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5582401	usd
CY2024Q2	us-gaap	Depreciation Depreciation	42297	usd
CY2023Q2	us-gaap	Depreciation Depreciation	92771	usd
	us-gaap	Depreciation Depreciation	85034	usd
	us-gaap	Depreciation Depreciation	184964	usd
CY2023	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss Writeoff DebtSecuritiesHeldToMaturityAllowanceForCreditLossWriteoff	750000	usd
CY2023	us-gaap	Debt Securities Held To Maturity Accrued Interest Writeoff DebtSecuritiesHeldToMaturityAccruedInterestWriteoff	129418	usd
CY2021Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2000000	usd
CY2021Q3	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1948234	usd
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.12	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.005	pure
CY2022Q3	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	500000	usd
CY2021Q4	sgbx	Principal Amount Of Promissory Note PrincipalAmountOfPromissoryNote	750000	usd
CY2021Q4	sgbx	Value Of Renovation Improvements ValueOfRenovationImprovements	750000	usd
CY2021Q4	sgbx	Size Of Manufacturing Facility SizeOfManufacturingFacility	58,000
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13244316	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11814717	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	677950	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	895222	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	12566366	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	10919495	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	10103921	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8472080	usd
CY2024Q2	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	2462445	usd
CY2023Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	2447415	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1225370	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	463114	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2024Q2	sgbx	Total Finance Lease Liabilities TotalFinanceLeaseLiabilities	463114	usd
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M1D
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	334112	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	133645	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	467757	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	4643	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	463114	usd
CY2023Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	1902332	usd
CY2022Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	6810762	usd
	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	4430208	usd
CY2023	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	11614650	usd
	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	73381	usd
CY2023	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet		usd
	sgbx	Construction Backlog Gross ConstructionBacklogGross	6259159	usd
CY2023	sgbx	Construction Backlog Gross ConstructionBacklogGross	18425412	usd
	sgbx	Contract Revenue ContractRevenue	2179369	usd
CY2023	sgbx	Contract Revenue ContractRevenue	16523080	usd
CY2024Q2	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	4079790	usd
CY2023Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	1902332	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4079790	usd
CY2021Q4	sgbx	Gross Proceeds GrossProceeds	11550000	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	10500000	usd
	sgbx	Stock Issued During Period Shares Under Economic Partnership Agreement StockIssuedDuringPeriodSharesUnderEconomicPartnershipAgreement	13355	shares
	sgbx	Stock Issued During Period Value Under Economic Partnership Agreement StockIssuedDuringPeriodValueUnderEconomicPartnershipAgreement	28867	usd
	sgbx	Stock Issued During Period Shares For Accounts Payable Settlement StockIssuedDuringPeriodSharesForAccountsPayableSettlement	129603	shares
	sgbx	Stock Issued During Period Value For Accounts Payable Settlement StockIssuedDuringPeriodValueForAccountsPayableSettlement	489268	usd
CY2024Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3590386	usd
	sgbx	Number Of Prefunded Warrants Exercised NumberOfPrefundedWarrantsExercised	279310	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	375000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	375000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.53
CY2024Q1	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	109161	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	251361	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1822	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	496
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1574.2
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1822	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	496
CY2024Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1574.2
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
CY2024Q2	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1822	shares
CY2023Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Files In Submission

Name	View Source	Status
0001213900-24-069089-index-headers.html	Edgar Link	pending
0001213900-24-069089-index.html	Edgar Link	pending
0001213900-24-069089.txt	Edgar Link	pending
0001213900-24-069089-xbrl.zip	Edgar Link	pending
ex311_3.htm	Edgar Link	pending
ex312_4.htm	Edgar Link	pending
ex321_5.htm	Edgar Link	pending
ex322_6.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20240630.htm	Edgar Link	pending
sgbx-20240630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sgbx-20240630_def.xml	Edgar Link	unprocessable
sgbx-20240630_lab.xml	Edgar Link	unprocessable
sgbx-20240630_pre.xml	Edgar Link	unprocessable
sgbx-20240630_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
sgbx-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2024 Q3 Form 10-Q Financial Statement

#000121390024069089 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2024 Q3 Form 10-Q Financial Statement

#000121390024069089 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx